Table 1 Clinical characteristics of the study population
From: pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients
| Â | HI | ESRD patients | P value |
|---|---|---|---|
Number of individuals | 24 | 24 | Â |
Age groups (years; mean ± SD) | |||
 young | 29,4 ± 5,6 | 34,6 ± 8,0 | ns |
 elderly | 70,5 ± 5,8 | 70,8 ± 4,2 | ns |
 Sex (% male) | 50 | 79,2 | ns |
 CMV IgG serostatus (% pos) | 62,5 | 62,5 | ns |
 RRT (number; %) |  | 11; (45,8%) |  |
 Duration of RRT in months (median with range) |  | 22 (1—37) |  |
 Hemodialysis (number) |  | 7 |  |
 Peritoneal dialysis (number) |  | 4 |  |
Underlying kidney disease (number; %) | |||
 atherosclerosis/hypertensive nephropathy |  | 8; (33%) |  |
 primary glomerulopathy |  | 4; (17%) |  |
 Diabetic nephropathy |  | 6; (25%) |  |
 congenital disorder |  | 3; (13%) |  |
 others |  | 2; (8%) |  |
 unknown |  | 1; (4%) |  |